View drug registration information details.


ItemsRegistration information
ID566
No566
Brand NameNEBILET TABLET
IngredientsNEBIVOLOL HYDROCHLORIDE 5.45 MG EQ.TO NEBIVOLOL 5 MG
Dosage FormTABLET
Primary PackagingPVC/AL -BLISTER
StorageSTORE BELOW 25 C
Shelf Life3 YEARS
Pack SizeBOX OF 14, 28, 30 TABLETS
Dispensing CategoryPRESCRIPTION
ATC ClassificationC07AB12
Pharmaceutical ClassANTIHYPERTENSIVE
IndicationsTREATMENT OF ESSENTIAL HYPERTENSION, TREATMENT OF STABLE MILD AND MODERATE CHRONIC HEART FAILURE IN ADDITION TO STANDARD THERAPIES IN ELDERLY PATIENTS>70 YEARS
ContraindicationsHYPERSENSITIVITY, LIVER INSUFFICIENCY OR LIVER FUNCTION IMPAIRMENT, ACUTE HEART FAILURE, CARDIOGENIC SHOCK OR EPISODE OF HEART FAILURE DECOMPENSATION REQUIRING I.V. INOTROPIC THERAPY
Side EffectsHEADACHE, DIZZINESS, PARAESTHESIA, DYSPNOEA, CONSTIPATION, NAUSEA, DIARRHEA, TIRENESS, OEDEMA
Unit Price
EDL No
DescriptionWHITE, ROUND, CROSS-SCORED TABLET.
Note
License OwnerDKSH LAOS COMPANY LIMITED
ManufacturerBERLIN-CHEMIE AG
CountryGERMANY
Import Registration No36893.00.00
Import Registration Date1996-06-20
ActivityCERTIFICATE RELEASED
Applied Date2021-12-03
FDD Registration No03 I 5438/23
FDD Registration Date2023-03-31
Expiry Date2026-03-30

Back to drug list